RxDoctor Payments Data

Dustin Carpenter, MD

Family Medicine · Mound City, MONPI 1396033072

Payments from drug & device makers

$1,304in general payments, 2019–2025

Across 82 payments — averaging $15.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$243
  • Novo Nordisk$200
  • AbbVie$185
  • E.r. Squibb & Sons, L.L.C.$117
  • AstraZeneca$71
  • Kowa Pharmaceuticals America, Inc.$71
  • plus $417 from 15 others

What the payments were for

  • Food & beverage$1,304100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,304 in reported general payments places this provider in the 65th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$25,469
Medicare patients
92
Services billed
409

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide81$87,388
EliquisApixaban117$48,195
Tresiba Flextouch U-200Insulin Degludec59$39,213
XareltoRivaroxaban42$31,989
FarxigaDapagliflozin Propanediol41$28,703
JardianceEmpagliflozin38$28,583
VraylarCariprazine Hcl16$23,178
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$22,425
JanuviaSitagliptin Phosphate25$19,720
MyrbetriqMirabegron30$19,176
RexultiBrexpiprazole12$17,703
Breztri AerosphereBudesonide/Glycopyr/Formoterol22$12,833
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr25$12,487
Advair HfaFluticasone Propion/Salmeterol25$12,347
Tresiba Flextouch U-100Insulin Degludec18$8,847

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$200$87,38881 claims
PfizerEliquis$42$48,195117 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$71$46,78776 claims
Boehringer IngelheimJardiance, Spiriva Respimat, Tradjenta$60$43,41766 claims
Johnson & JohnsonXarelto$45$31,98942 claims
AbbVieVraylar$185$23,17816 claims
Otsuka America Pharmaceutical, Inc.Rexulti$34$17,70312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Mound City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →